A novel Bcr-Abl splice isoform is associated with the L248V mutation in CML patients with acquired resistance to imatinib (Q57271955)

From Wikidata
Jump to navigation Jump to search
scientific article published on 28 September 2006
edit
Language Label Description Also known as
English
A novel Bcr-Abl splice isoform is associated with the L248V mutation in CML patients with acquired resistance to imatinib
scientific article published on 28 September 2006

    Statements

    A novel Bcr-Abl splice isoform is associated with the L248V mutation in CML patients with acquired resistance to imatinib (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit